Kidney International ReportsAssociations of chronic kidney disease (CKD) with metabolic syndrome and cardiovascular disease (CVD) have long been recognized. Until recently, such associations were mainly limited to interrelationships between either heart and kidney, heart and ...
Ziad A. Massy, Tilman B. Drueke
doaj +4 more sources
Association between vascular aging and cardiovascular-kidney-metabolic syndrome [PDF]
Frontiers in EndocrinologyBackgroundThe concept of Cardiovascular-Kidney-Metabolic syndrome (CKM), an intricate interplay among metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system, was introduced by the American Heart Association (AHA).
Shuyi Zeng +7 more
doaj +4 more sources
Exercise rehabilitation in cardiovascular-kidney-metabolic syndrome: a narrative review [PDF]
Frontiers in Cardiovascular MedicineCardiovascular-Kidney-Metabolic Syndrome (CKM) is a multi-organ dysfunction syndrome driven by the interaction of metabolic risk factors, chronic kidney disease, and cardiovascular disease, culminating in adverse cardiovascular events.
Min Sun +4 more
doaj +2 more sources
From Metabolic Syndrome to Cardiovascular–Kidney–Metabolic Syndrome (CKM): A Clinical and Pathophysiological Continuum [PDF]
BiomedicinesCardiovascular–kidney–metabolic (CKM) syndrome has emerged as a broader clinical and pathophysiological framework than traditional metabolic syndrome, addressing the limitations of a purely factor-clustering approach by integrating dysfunctional ...
Carlo Acierno +4 more
doaj +2 more sources
Sex differences in the progression of cardiovascular-kidney-metabolic syndrome. [PDF]
Eur Heart J OpenAbstract Aims Cardiovascular–kidney–metabolic (CKM) syndrome is a novel disease concept; however, sex differences in its progression remain uncertain. This study aimed to quantify the risk of cardiovascular disease (CVD) events across CKM stages and to explore sex differences in this ...
Taya S +18 more
europepmc +3 more sources
Current understanding of sodium-glucose transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome [PDF]
Frontiers in PharmacologyCardiovascular-kidney-metabolic (CKM) syndrome is a recently defined clinical entity that encompasses cardiovascular disease (CVD), chronic kidney disease (CKD) and metabolic disorders.
Yan Yang +4 more
doaj +2 more sources
Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Healthcare (Basel)Cardiovascular–Kidney–Metabolic (CKM) syndrome arises from interrelated cardiovascular, renal, and metabolic pathways that require coordinated therapeutic strategies. This narrative review synthesizes recent systematic reviews, meta-analyses, and original studies to evaluate the translational application of lifestyle medicine (LM) for CKM management ...
Papadakis Z.
europepmc +3 more sources
Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study [PDF]
PharmaceuticalsIntroduction and Objectives: There is limited evidence on the role of glucagon-like peptide-1 receptor agonists in the interplay between cardiovascular disease, chronic kidney disease, and metabolic dysfunction. This work analyzed the efficacy and safety
Alicia Trenas-Calero +8 more
doaj +2 more sources
Social Determinants of Health in the Development of Cardiovascular-kidney-metabolic Syndrome
Reviews in Cardiovascular MedicineCardiovascular-kidney-metabolic (CKM) syndrome is characterized by the interactions among the metabolic risk factors, chronic kidney diseases (CKD) and cardiovascular diseases (CVD).
Xinyi Cai, Tuo Li
doaj +3 more sources
Preeclampsia as an early manifestation of cardiovascular–kidney–metabolic syndrome [PDF]
Frontiers in PhysiologyPriscila Oliveira Barbosa +5 more
doaj +2 more sources